{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:25:50Z","timestamp":1781969150007,"version":"3.54.5"},"reference-count":72,"publisher":"Baishideng Publishing Group Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJGO"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4251\/wjgo.v4.i3.60","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T14:14:18Z","timestamp":1331820858000},"page":"60","source":"Crossref","is-referenced-by-count":40,"title":["Tumors of ampulla of Vater: A case series and review of chemotherapy options"],"prefix":"10.4251","volume":"4","author":[{"given":"Adriana","family":"Romiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2005.08.002"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199807000-00013"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/S00534-004-0894-7"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200407000-00005"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880270"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1994.tb02077.x"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/S00428-007-0444-1"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000149708.12335.6a"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/pas.0b013e3181983ef7"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.030098"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.134.5.526"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2006.04.006"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199806000-00005"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198910000-00015"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-9886-1"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpa.0000220864.80034.63"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2004.03.010"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7498-x"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.138.9.941"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20665"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-006-0213-3"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-0117-6"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2003.07.512"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9537-y"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9136-3"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2008.01.028"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-170"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2482-2-1"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.20523"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2007.03.1081"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(95)02132-9"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199506000-00017"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21409"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.03.036"},{"key":"ref35","unstructured":"Nakano K, Chijiiwa K, Toyonaga T, Ueda J, Takamatsu Y, Kimura M, Nakamura K, Yamaguchi K, Tanaka M. Combination therapy of resection and intraoperative radiation for patients with carcinomas of extrahepatic bile duct and ampulla of Vater: prognostic advantage over resection alone? Hepatogastroenterology 2003;50:928-933."},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-782; discussion 782-784.","DOI":"10.1097\/00000658-199912000-00006"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2004.08.013"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.04.018"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318156eef3"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.07.2327"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318190c53e"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.11.067"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2009.05.006"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-345"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-6-126"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10831"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032295"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.3.267"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Neuhaus P, Riess H, Post S, Gellert K, Ridwelski K, Schramm H, Zuelke C, Fahlke J, Langrehr J, Oettle H, Deutsche Krebsgesellschaft (CAO\/AIO). CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC). J Clin Oncol 2008;26 Suppl:abstr LBA4504.","DOI":"10.1200\/jco.2008.26.15_suppl.lba4504"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.9.1019"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-009-0900-0"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Neoptolemos JP, Moore MJ, Cox TF, Valle JW, Palmer DH, Mcdonald A, Carter R, Tebbutt NC, Dervenis C, Smith D, Glimelius B, Coxon FY, Lacaine F, Middleton MR, Ghaneh P, Bassi C, Halloran C, Olah A, Rawcliffe CL, Büchler MW, European Study Group for Pancreatic Cancer. Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater. J Clin Oncol 2011;29 Suppl:abstr LBA4006.","DOI":"10.1200\/jco.2011.29.18_suppl.lba4006"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-007-1281-y"},{"key":"ref54","unstructured":"Key C, Meisner ALW. Cancers of the liver and biliary tract. SEER survival monograph: cancer survival among adults: US SEER Program, 1988-2001, patient and tumor characteristics Bethesda, MD: National Cancer Institute, SEER Program; 2007;49-58."},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Glimelius B, Hoffman K, Sjödén PO, Jacobsson G, Sellström H, Enander LK, Linné T, Svensson C. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996;7:593-600.","DOI":"10.1093\/oxfordjournals.annonc.a010676"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603648"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605211"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604628"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00323-B"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1159\/000070310"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602576"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-003-0534-7"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-2-132"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.7145"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-009-9351-4"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh351"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.51.008"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24970"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70247-3"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Malka D, Trarbach T, Fartoux L, Mendiboure J, de la Fouchardière C, Viret F, Assenat E, Boucher E, Rosmorduc O, Greten T. A multicenter, randomized phase II trial of gemcitabine and oxaliplatin (GEMOX) alone or in combination with biweekly cetuximab in the first-line treatment of advanced biliary cancer: Interim analysis of the BINGO trial. J Clin Oncol 2009;27 Suppl:Abstr 4520.","DOI":"10.1200\/jco.2009.27.15_suppl.4520"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604129"}],"container-title":["World Journal of Gastrointestinal Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T15:14:08Z","timestamp":1641222848000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5204\/full\/v4\/i3\/60.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.4251\/wjgo.v4.i3.60","relation":{},"ISSN":["1948-5204"],"issn-type":[{"value":"1948-5204","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}